APA (7th ed.) Citation

Gangat, N., Karrar, O., Iftikhar, M., McCullough, K., Johnson, I. M., Abdelmagid, M., . . . Tefferi, A. (2024). Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology, 99(2), 193-202. https://doi.org/10.1002/ajh.27138

Chicago Style (17th ed.) Citation

Gangat, Naseema, et al. "Venetoclax and Hypomethylating Agent Combination Therapy in Newly Diagnosed Acute Myeloid Leukemia: Genotype Signatures for Response and Survival Among 301 Consecutive Patients." American Journal of Hematology 99, no. 2 (2024): 193-202. https://doi.org/10.1002/ajh.27138.

MLA (9th ed.) Citation

Gangat, Naseema, et al. "Venetoclax and Hypomethylating Agent Combination Therapy in Newly Diagnosed Acute Myeloid Leukemia: Genotype Signatures for Response and Survival Among 301 Consecutive Patients." American Journal of Hematology, vol. 99, no. 2, 2024, pp. 193-202, https://doi.org/10.1002/ajh.27138.